FMTX - Forma Therapeutics Holdings Inc. (FMTX) CEO Frank Lee on Q2 2021 Results - Earnings Call Transcript
Forma Therapeutics Holdings, Inc. (FMTX) Q2 2021 Results Conference Call August 13, 2021 08:00 AM ET Company Participants Mario Corso - Senior Director-Investor Relations Frank Lee - President & Chief Executive Officer Pat Kelly - Chief Medical Officer Dave Cook - Chief Scientific Officer Todd Shegog - Chief Financial Officer Conference Call Participants Emma Nealon - Cantor Fitzgerald Tiago Fauth - Credit Suisse Maury Raycroft - Jefferies Mark Breidenbach - Oppenheimer Robin Garner - Craig-Hallum Presentation Operator Welcome to the Forma Therapeutics Second Quarter 2021 Financial Results and Business Update Conference Call. All participants are currently in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, August 13, 2021. I would now like to turn the conference over to Mario Corso. Please go ahead. Mario Corso Thank you, Gigi. This is Mario Corso, Senior Director
For further details see:
Forma Therapeutics Holdings, Inc. (FMTX) CEO Frank Lee on Q2 2021 Results - Earnings Call Transcript